Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Lansoprazole ODT (GH) (lansoprazole 15 mg) orally disintegrating tablet, 28 tablets, blister pack (containered trade product pack) |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 15 mg orally disintegrating tablet, 7, blister pack |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 30 mg orally disintegrating tablet |
Is a |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 30 mg orally disintegrating tablet, 7 |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 30 mg orally disintegrating tablet, 28 |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) (lansoprazole 15 mg) orally disintegrating tablet (trade product unit of use) |
Is a |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 15 mg orally disintegrating tablet, 7 |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 15 mg orally disintegrating tablet, 28 |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 30 mg orally disintegrating tablet, 7, blister pack |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|
Lansoprazole ODT (GH) 30 mg orally disintegrating tablet, 28, blister pack |
has TP |
True |
Lansoprazole ODT (GH) |
Inferred relationship |
Some |
|